⌘K
Loading ticker…
Trevi Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Trevi Therapeutics, Inc. Common Stock (TRVI) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 78. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.1%, relative volume 3.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 90, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TRVI is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 23.7% / 50.2%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
TRVI is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $44M notional. Top 3 carry $86M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $44M |
| IWMiShares Russell 2000 ETF | 0.04% | $28M |
| VXFVanguard Extended Market ETF | 0.02% | $14M |
| IWOiShares Russell 2000 Growth ETF | 0.08% | $9M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.92% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TRVI Jan avg: 1.49% median: 0.80% win: 50% σ: 15.74% n: 4 2022-04-12 → 2026-05-29 | TRVI Feb avg: 34.20% median: 14.29% win: 100% σ: 47.95% n: 4 2022-04-12 → 2026-05-29 | TRVI Mar avg: 8.70% median: 9.12% win: 75% σ: 26.27% n: 4 2022-04-12 → 2026-05-29 | TRVI Apr avg: 19.07% median: 9.86% win: 60% σ: 39.14% n: 5 2022-04-12 → 2026-05-29 | TRVI May avg: -12.58% median: -10.37% win: 20% σ: 14.94% n: 5 2022-04-12 → 2026-05-29 | TRVI Jun avg: 6.69% median: 13.30% win: 75% σ: 15.32% n: 4 2022-04-12 → 2026-05-29 (current) | TRVI Jul avg: 12.64% median: 7.80% win: 75% σ: 15.67% n: 4 2022-04-12 → 2026-05-29 | TRVI Aug avg: -1.47% median: -1.33% win: 25% σ: 4.56% n: 4 2022-04-12 → 2026-05-29 | TRVI Sep avg: -5.28% median: 2.17% win: 50% σ: 32.99% n: 4 2022-04-12 → 2026-05-29 | TRVI Oct avg: 6.46% median: 7.80% win: 50% σ: 25.02% n: 4 2022-04-12 → 2026-05-29 | TRVI Nov avg: -7.73% median: -3.63% win: 25% σ: 20.96% n: 4 2022-04-12 → 2026-05-29 | TRVI Dec avg: 14.94% median: 10.88% win: 75% σ: 21.29% n: 4 2022-04-12 → 2026-05-29 |